BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...

July 17, 2024 | News

Calliditas Therapeutics and Viatris Initiate Phase III Trial for IgA Nephropathy in Japan

Calliditas Therapeutics AB announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in&...

July 05, 2024 | News

Endogenex Secures $88 Million in Oversubscribed Series C Financing to Advance Diabetes Treatment

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubs...

June 26, 2024 | News

Chinese Researchers Demonstrate Significant Cardiovascular Benefits of Early Insulin Therapy in Diabetes

Recently, Professor Jianping Weng of the University of Science and Technology of China (USTC) and President of Anhui Medical University and ...

June 20, 2024 | Report

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | News

Cynata Therapeutics Completes Patient Enrolment for Diabetic Foot Ulcer Trial

Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,&n...

April 08, 2024 | News

Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study

Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...

January 31, 2024 | News

IDF and Sanofi Partner to Boost Diabetes Response in 40 Nations

The International Diabetes Federation (IDF), in collaboration with Sanofi's Global Health Unit (GHU), is taking significant steps to improve...

January 16, 2024 | News

Glenmark Launches First Biosimilar of Liraglutide, a Popular Anti-Diabetic Drug in India

‐ The anti‐diabetic biosimilar has been launched under the brand name Lirafit™, and is indicated for improving glycemic control in adult ...

January 03, 2024 | News

What Is the Glycemic Index? Understanding Low vs. High Glycemic Carbohydrates

If you have diabetes, you're probably well aware that some foods elevate blood sugar levels more than others after a meal. This is called postprandia...

November 19, 2023 | News

Eccogene and AstraZeneca Partner on ECC5004 for Cardiometabolic Diseases

Eccogene will receive initial upfront payment of $185 million. Eccogene is also eligible to receive up to $1.825 billion in future clinical,...

November 10, 2023 | News

NUS Scientists Create Magnetic Gel Speeding Up Diabetic Wound Healing 3x

Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-healing wounds co...

October 20, 2023 | News

Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.

In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...

October 11, 2023 | News

RSSDI-Sanofi Type 1 Diabetes Program Yields Positive Results in India

Type 1 Diabetes program by RSSDI and Sanofi’s Social impact initiative has been delivering positive outcomes The three-year ongoing co...

September 26, 2023 | Analysis

Stay Connected